Novavax Inc. $NVAX shares experienced a sharp rise following the announcement that the US Food and Drug Administration (FDA) granted full approval for its Covid-19 vaccine. This development alleviated investor concerns after previous delays in authorization and public doubts voiced by US Secretary of Health and Human Services, Robert F. Kennedy Jr., regarding the product's effectiveness.